Bazedoxifene as a Concomitant Treatment of Patients With Metastatic Pancreatic Adenocarcinoma
Latest Information Update: 06 Jun 2024
At a glance
- Drugs Bazedoxifene (Primary) ; Gemcitabine; Paclitaxel; Pantoprazole; Rivaroxaban
- Indications Adenocarcinoma; Cancer metastases; Pancreatic cancer
- Focus Therapeutic Use
- Acronyms BAZE
- 06 Jun 2024 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified Feb 2022).
- 09 Feb 2022 Status changed from not yet recruiting to recruiting.
- 15 Oct 2021 Aspirin (Oral) has been replaced by Rivaroxaban (Xarelto, oral) in the treatments section.